Pharmabiz31m
Vir Biotech gets US FDA breakthrough therapy designation & EMA PRIME designation for tobevibart, elebsiran to treat chronic hepatitis delta
Vir Biotechnology, Inc, a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and ...
Pharmabiz5h
UP govt to provide one 100-bed, two 20-bed, small 8-bed hospitals at Prayagraj Mahakumbh-2025
The Uttar Pradesh government will provide one 100-bed, two 20-bed, small 8-bed hospital at Prayagraj Mahakumbh-2025 as a part ...
Pharmabiz1h
Bayer initiates phase I study with SOS1 inhibitor, BAY3498264 in patients with advanced KRAS-mutated tumours
Bayer initiates phase I study with SOS1 inhibitor, BAY3498264 in patients with advanced KRAS-mutated tumours: Berlin Saturday, December 14, 2024, 13:00 Hrs [IST] Bayer announced i ...
Pharmabiz2h
BeiGene enters global licensing agreement CSPC Zhongqi Pharmaceutical for MAT2A inhibitor for solid tumours
BeiGene, Ltd., a global oncology company that intends to change its name to BeOne Medicines Ltd., announced it has entered into a global licensing agreement with CSPC Zhongqi Pharmaceutical Technology ...
Pharmabiz21h
Health and wellness industry set to witness a transformative innovation with the launch of Auffüllen
Health and wellness industry set to witness a transformative innovation with the launch of Auffüllen: Our Bureau, Mumbai ...
Pharmabiz22h
Sahyadri Hospitals in partnership with Dozee introduces Maharashtra’s first AI-Powered Command Centre initiative for enhanced patient safety
Sahyadri Hospitals in partnership with Dozee introduces Maharashtra’s first AI-Powered Command Centre initiative for enhanced ...
Pharmabiz15h
Foreign delegates attending WAC hail PM’s global advocacy for Ayurveda
With Ayurveda gaining mass popularity in many countries, international delegates came together at the 10th World Ayurveda ...
Pharmabiz4h
EMA approves Roche’s Vabysmo prefilled syringe for three retinal conditions that can cause blindness
EMA approves Roche’s Vabysmo prefilled syringe for three retinal conditions that can cause blindness: Basel Saturday, December 14, 2024, 10:00 Hrs [IST] Roche announced that the ...
Pharmabiz17h
Eikonizo Therapeutics secures equity investment from Novo Nordisk to advance its lead candidate EKZ-102
Eikonizo Therapeutics, a biopharmaceutical company dedicated to developing disease-modifying therapies to improve the lives of people impacted by neurodegenerative and cardiorenal diseases, announced ...
Pharmabiz6h
Pharmacy career immune to recession, economic downturns; offers diverse job avenues
Pharmacy career immune to recession, economic downturns; offers diverse job avenues: Nandita Vijayasimha, Bengaluru Saturday, December 14, 2024, 08:00 Hrs [IST] Pharmacy career is ...
Pharmabiz6h
Indian pharma industry set to make a mark at Clinical Pharmacy Congress London 2025
Indian pharma industry set to make a mark at Clinical Pharmacy Congress London 2025: Shardul Nautiyal, Mumbai Saturday, December 14, 2024, 08:00 Hrs [IST] The Indian pharmaceutica ...
Pharmabiz1h
AI, robotics and sustainability to propel more personalized healthcare ecosystem in 2025: Atul Kurani
The healthcare industry is on the brink of a paradigm shift, with groundbreaking technologies and evolving patient behaviours driving a transition toward a more personalized and sustainable care ...